Literature DB >> 33804510

Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients.

Kendrick Koo1,2,3,4, Dmitri Mouradov1,2, Christopher M Angel5, Tim A Iseli3, David Wiesenfeld3,4, Michael J McCullough4, Antony W Burgess1,2,3, Oliver M Sieber1,2,3,6.   

Abstract

Molecular alterations in 176 patients with oral squamous cell carcinomas (OSCC) were evaluated to delineate differences in non-smoking non-drinking (NSND) patients. Somatic mutations and DNA copy number variations (CNVs) in a 68-gene panel and human papilloma virus (HPV) status were interrogated using targeted next-generation sequencing. In the entire cohort, TP53 (60%) and CDKN2A (24%) were most frequently mutated, and the most common CNVs were EGFR amplifications (9%) and deletions of BRCA2 (5%) and CDKN2A (4%). Significant associations were found for TP53 mutation and nodal disease, lymphovascular invasion and extracapsular spread, CDKN2A mutation or deletion with advanced tumour stage, and EGFR amplification with perineural invasion and extracapsular spread. PIK3CA mutation, CDKN2A deletion, and EGFR amplification were associated with worse survival in univariate analyses (p < 0.05 for all comparisons). There were 59 NSND patients who tended to be female and older than patients who smoke and/or drink, and showed enrichment of CDKN2A mutations, EGFR amplifications, and BRCA2 deletions (p < 0.05 for all comparisons), with a younger subset showing higher mutation burden. HPV was detected in three OSCC patients and not associated with smoking and drinking habits. NSND OSCC exhibits distinct genomic profiles and further exploration to elucidate the molecular aetiology in these patients is warranted.

Entities:  

Keywords:  CDKN2A; DNA copy number; EGFR; PIK3CA; TP53; alcohol; human papilloma virus; oral cancer; targeted sequencing; tobacco

Year:  2021        PMID: 33804510      PMCID: PMC7957667          DOI: 10.3390/cancers13051029

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  61 in total

1.  Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.

Authors:  I Tinhofer; V Budach; M Saki; R Konschak; F Niehr; K Jöhrens; W Weichert; A Linge; F Lohaus; M Krause; K Neumann; V Endris; A Sak; M Stuschke; P Balermpas; C Rödel; M Avlar; A L Grosu; A Abdollahi; J Debus; C Belka; S Pigorsch; S E Combs; D Mönnich; D Zips; M Baumann
Journal:  Eur J Cancer       Date:  2016-02-18       Impact factor: 9.162

2.  CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.

Authors:  Kit W Tam; Wei Zhang; Junichi Soh; Victor Stastny; Min Chen; Han Sun; Kelsie Thu; Jonathan J Rios; Chenchen Yang; Crystal N Marconett; Suhaida A Selamat; Ite A Laird-Offringa; Ayumu Taguchi; Samir Hanash; David Shames; Xiaotu Ma; Michael Q Zhang; Wan L Lam; Adi Gazdar
Journal:  J Thorac Oncol       Date:  2013-11       Impact factor: 15.609

3.  The mutational landscape of head and neck squamous cell carcinoma.

Authors:  Nicolas Stransky; Ann Marie Egloff; Aaron D Tward; Aleksandar D Kostic; Kristian Cibulskis; Andrey Sivachenko; Gregory V Kryukov; Michael S Lawrence; Carrie Sougnez; Aaron McKenna; Erica Shefler; Alex H Ramos; Petar Stojanov; Scott L Carter; Douglas Voet; Maria L Cortés; Daniel Auclair; Michael F Berger; Gordon Saksena; Candace Guiducci; Robert C Onofrio; Melissa Parkin; Marjorie Romkes; Joel L Weissfeld; Raja R Seethala; Lin Wang; Claudia Rangel-Escareño; Juan Carlos Fernandez-Lopez; Alfredo Hidalgo-Miranda; Jorge Melendez-Zajgla; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz; Todd R Golub; Levi A Garraway; Jennifer R Grandis
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

4.  Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.

Authors:  C H Chung; V B Guthrie; D L Masica; C Tokheim; H Kang; J Richmon; N Agrawal; C Fakhry; H Quon; R M Subramaniam; Z Zuo; T Seiwert; Z R Chalmers; G M Frampton; S M Ali; R Yelensky; P J Stephens; V A Miller; R Karchin; J A Bishop
Journal:  Ann Oncol       Date:  2015-02-23       Impact factor: 32.976

5.  Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.

Authors:  Kristina R Dahlstrom; Jarrod A Little; Mark E Zafereo; Margaret Lung; Qingyi Wei; Erich M Sturgis
Journal:  Head Neck       Date:  2008-01       Impact factor: 3.147

6.  Mutational signatures associated with tobacco smoking in human cancer.

Authors:  Ludmil B Alexandrov; Young Seok Ju; Kerstin Haase; Peter Van Loo; Iñigo Martincorena; Serena Nik-Zainal; Yasushi Totoki; Akihiro Fujimoto; Hidewaki Nakagawa; Tatsuhiro Shibata; Peter J Campbell; Paolo Vineis; David H Phillips; Michael R Stratton
Journal:  Science       Date:  2016-11-04       Impact factor: 47.728

7.  The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Authors:  Nicole G Chau; Bayardo Perez-Ordonez; Katherine Zhang; Nhu-An Pham; James Ho; Tong Zhang; Olga Ludkovski; Lisa Wang; Eric X Chen; Ming-Sound Tsao; Suzanne Kamel-Reid; Lillian L Siu
Journal:  Head Neck Oncol       Date:  2011-02-27

8.  EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma.

Authors:  Oliver Bissinger; Andreas Kolk; Enken Drecoll; Melanie Straub; Christina Lutz; Klaus-Dietrich Wolff; Carolin Götz
Journal:  Exp Ther Med       Date:  2017-09-18       Impact factor: 2.447

9.  Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis.

Authors:  I-H Chen; J T Chang; C-T Liao; H-M Wang; L-L Hsieh; A-J Cheng
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

10.  Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.

Authors: 
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  3 in total

Review 1.  Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.

Authors:  Pavel Hurník; Zuzana Chyra; Tereza Ševčíková; Jan Štembírek; Kateřina Smešný Trtková; Daria A Gaykalova; Marcela Buchtová; Eva Hrubá
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.772

2.  Squamous Cell Carcinoma-A Summary of Novel Advances in Pathogenesis and Therapies.

Authors:  Imran Khan; Charbel Darido
Journal:  Cancers (Basel)       Date:  2022-05-20       Impact factor: 6.575

3.  Comparison between three age-stratified cohorts reveals poor prognosis of young patients with tongue carcinoma.

Authors:  Daisuke Baba; Kazuto Matsuura; Masashi Wakabayashi; Yohei Morishita; Yukio Nishiya; Wataru Okano; Toshifumi Tomioka; Takeshi Shinozaki; Ryuichi Hayashi
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.